BeStock  
Stocks › Biotechnology › SRRK

Scholar Rock SRRK

US equityMarket cap rank #1884Biotechnology
$48.13 −$2.24 (-4.45%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $48.13 0.00%
Open$49.63
Prev close$50.37
Day range$47.94 – $52.17
Volume2.08M
Market cap$5.87B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.5%last 12 reports
Closed higher5 of 1242% of the time
Best reaction+24.4%
Worst reaction-6.9%

Stock move on the day after each report

+2.3%2020/Q2+1.5%2023/Q3-1.0%2024/Q2-5.3%2024/Q3-2.9%2024/Q4-2.7%2025/Q1-6.4%2025/Q2+24.4%2025/Q3+1.9%2025/Q4-1.4%2026/Q1+10.0%2026/Q2-6.9%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q310 Nov 2026Pre Market±8.8%-6.89%Within range
2026/Q26 Aug 2026Pre Market±9.5%+9.96%Bigger than priced
2026/Q17 May 2026Pre Market±10.1%-1.40%Within range
2025/Q43 Mar 2026Pre Market±13.4%+1.91%Within range
2025/Q314 Nov 2025Pre Market±10.1%+24.41%Bigger than priced
2025/Q26 Aug 2025Pre Market±18.9%-6.40%Within range
2025/Q114 May 2025Pre Market±11.6%-2.74%Within range
2024/Q427 Feb 2025Pre Market±21.3%-2.86%Within range
2024/Q312 Nov 2024Pre Market±15.5%-5.29%Within range
2024/Q28 Aug 2024Pre Market±28.1%-0.97%Within range
2023/Q37 Nov 2023Pre Market±24.0%+1.48%Within range
2020/Q27 Aug 2020None–+2.25%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$570,000.00
Operating profit-$106.06M-2.4% YoY
Net profit-$107.24M-4.9% YoY
Diluted EPS-$0.81+10.0% YoY
Free cash flow-$81.91M-18.7% YoY
Operating cash flow-$81.81M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$570.0KSep '26

Net profit, last 8 quarters

$-66.5MDec '24$-74.7MMar '25$-110.0MJun '25$-102.2MSep '25$-91.0MDec '25$-105.5MMar '26$-109.9MJun '26$-107.2MSep '26

Profitability & balance sheet

Gross margin98.6%
Operating margin-71,732.3%
Net margin-72,563.2%
Return on equity-200.0%
Return on assets-96.4%
Return on invested capital-114.0%
Current ratio5.41
Liabilities / assets62.2%
Cash & investments$413.60M
Total debt$197.17M
Net cash (debt)$216.43M

Discussion

No comments yet — be the first to weigh in on SRRK.

Sign in to join the discussion.

Scroll to Top